Benzinga's Top #PreMarket Gainers

Sarepta Therapeutics SRPT soared 75.37% to $42.79 in the pre-market trading on announcement that it will file NDA for Eteplirsen for the treatment of Duchenne Muscular Dystrophy by the year-end. Prosensa Holding NV RNA shares gained 27.22% to $6.45 in the pre-market after jumping 8.33% on Thursday. Momenta Pharmaceuticals MNTA shares jumped 13.06% to $12.55 in pre-market trading after dropping 3.98% on Thursday. AstraZeneca PLC AZN surged 6.49% to $67.62 in the pre-market session on the report of potential acquisition by Pfizer PFE.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPre-Market OutlookMarketsMoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!